MicroPort Scientific (00853.HK) Receives Approval to Spin Off MicroPort CardioFlow for Independent Main Board Listing
MicroPort CardioFlow
A Provider of High-End Interventional Medical Devices in the Cardiac Valve Field, Engaged in R&D, Manufacturing, Sales, and Related Technical Consulting Services
MicroPort
High-end Medical Device R&D and Manufacturer
Original Title: MicroPort (00853.HK) Approved to Spin Off MicroPort CardioFlow for Independent Listing on Main Board Source: Aastocks Financial News
MicroPort (00853.HK) announced that the Stock Exchange of Hong Kong has confirmed that the Company may proceed with the proposed spin-off and separate listing of MicroPort CardioFlow Medtech Corporation on the Main Board. On the 6th of this month, MicroPort CardioFlow submitted its listing application to the Stock Exchange. Details regarding the global offering have not yet been finalized.
MicroPort CardioFlow is primarily engaged in the research and development, manufacturing, and sales of devices for the treatment of valvular heart disease. The Company currently holds a 50.06% equity interest in MicroPort CardioFlow. Upon completion of the spin-off, MicroPort CardioFlow is expected to remain a subsidiary of the Company. (de/d) (Quotes are delayed by at least 15 minutes. Short-selling data as of 2020-11-06 16:25.)